Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | FNTA | P49354 | 2/20 | 0.37 |
| ▸ | FNTB | P49356 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13344643 | 0.95 | EGFR (0.40) | ALDH1A1EGFRKDM4EPOLB | |
| SCHEMBL17226387 | 0.87 | PTGS1 (0.37) | ALDH1A1LMNAMAPK1KDM4EBCHE | |
| SCHEMBL13310455 | 0.84 | PTGS1 (0.36) | ALDH1A1LMNAMAPK1FNTAFNTB | |
| SCHEMBL13310457 | 0.82 | PTGS1 (0.41) | ALDH1A1LMNAMAPK1KDM4EBCHE | |
| SCHEMBL17372277 | 0.79 | ALDH1A1 (0.40) | ALDH1A1LMNAMAPK1EGFRKDM4E | |
| SCHEMBL2251832 | 0.77 | PTGS1 (0.54) | ALDH1A1LMNAMAPK1KDM4EBCHE | |
| SCHEMBL30249167 | 0.77 | PDF (0.39) | LMNAMAPK1FNTAFNTBKDM4E | |
| SCHEMBL13310458 | 0.76 | ALDH1A1 (0.43) | ALDH1A1LMNAMAPK1KDM4EBCHE | |
| SCHEMBL17368894 | 0.76 | ALDH1A1 (0.37) | ALDH1A1LMNAMAPK1EGFRKDM4E | |
| SCHEMBL12334352 | 0.76 | MAOB (0.37) | ALDH1A1LMNAMAPK1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100132796-A1 | DYE COMPOUND FOR DYE-SENSITIZED SOLAR CELLS, DYE-SENSITIZED PHOTOELECTRIC CONVERTER AND DYE-SENSITIZED SOLAR CELLS | SAMSUNG ELECTRO-MECHANICS CO., LTD. | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100132796-A1 | DYE COMPOUND FOR DYE-SENSITIZED SOLAR CELLS, DYE-SENSITIZED PHOTOELECTRIC CONVERTER AND DYE-SENSITIZED SOLAR CELLS | CRY1, XPA, C1S | ALDH1A1 971/4885LMNA 1371/4885MAPK1 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.